Tag: WHO GMP guidelines

How to Train Your Staff to Meet Schedule M (Revised) GMP Requirements

Posted on By digi

How to Train Your Staff to Meet Schedule M (Revised) GMP Requirements Effective Training Strategies to Ensure Compliance with Schedule M (Revised) GMP Standards Introduction to Staff Training and Schedule M (Revised) The successful implementation of Schedule M (Revised) Good Manufacturing Practices (GMP) relies heavily on a well-trained workforce. Staff at all levels of a…

Read More “How to Train Your Staff to Meet Schedule M (Revised) GMP Requirements” »

SCHEDULE - M - Revised

How PMDA GMP Promotes Drug Quality Control in Japan

Posted on By digi

How PMDA GMP Promotes Drug Quality Control in Japan How PMDA GMP Promotes Drug Quality Control in Japan Introduction to PMDA GMP and Drug Quality Control Drug quality control is essential to ensure that pharmaceutical products meet safety, efficacy, and quality standards before reaching consumers. In Japan, the Pharmaceutical and Medical Devices Agency (PMDA) enforces…

Read More “How PMDA GMP Promotes Drug Quality Control in Japan” »

PMDA GMP Guidelines

Common ANVISA GMP Violations and How to Address Them

Posted on By digi

Common ANVISA GMP Violations and How to Address Them Common ANVISA GMP Violations and How to Address Them Introduction to ANVISA GMP Violations The National Health Surveillance Agency (ANVISA) is the regulatory body responsible for ensuring the safety, quality, and efficacy of pharmaceutical products in Brazil. One of the primary ways ANVISA enforces its regulatory…

Read More “Common ANVISA GMP Violations and How to Address Them” »

GMP in Latin America (ANVISA, COFEPRIS)

The Role of EMA GMP in the Manufacture of Orphan Drugs

Posted on By digi

The Role of EMA GMP in the Manufacture of Orphan Drugs Ensuring Quality and Compliance in the Manufacture of Orphan Drugs with EMA GMP Introduction to Orphan Drugs and EMA GMP Standards Orphan drugs are pharmaceutical products developed to treat rare diseases, often affecting fewer than 1 in 2,000 people in the European Union (EU)….

Read More “The Role of EMA GMP in the Manufacture of Orphan Drugs” »

EMA GMP Guidelines

How TGA GMP Helps Prevent Counterfeit Drugs in Australia

Posted on By digi

How TGA GMP Helps Prevent Counterfeit Drugs in Australia The Role of TGA GMP in Combating Counterfeit Drugs in Australia Introduction to Counterfeit Drugs and TGA GMP Counterfeit drugs pose a significant threat to public health, undermining patient safety and the integrity of the pharmaceutical industry. These falsified medicines may lack active ingredients, contain harmful…

Read More “How TGA GMP Helps Prevent Counterfeit Drugs in Australia” »

TGA GMP Guidelines

How NMPA GMP Guidelines Support Sustainable Practices in Pharma Manufacturing

Posted on By digi

How NMPA GMP Guidelines Support Sustainable Practices in Pharma Manufacturing How NMPA GMP Guidelines Support Sustainable Practices in Pharma Manufacturing Introduction to NMPA GMP and Sustainability in Pharma Manufacturing The pharmaceutical industry is facing growing pressure to adopt sustainable practices in response to environmental concerns, resource limitations, and increasing regulatory expectations. In China, the National…

Read More “How NMPA GMP Guidelines Support Sustainable Practices in Pharma Manufacturing” »

NMPA GMP Guidelines

How WHO GMP Compliance Supports Pharmaceutical Supply Chains

Posted on By digi

How WHO GMP Compliance Supports Pharmaceutical Supply Chains The Role of WHO GMP Compliance in Strengthening Pharmaceutical Supply Chains Introduction to WHO GMP and Supply Chains The pharmaceutical supply chain is a complex network that includes raw material suppliers, manufacturers, distributors, and healthcare providers. Ensuring the safety, quality, and efficacy of medicines across this chain…

Read More “How WHO GMP Compliance Supports Pharmaceutical Supply Chains” »

WHO GMP Guidelines

The Role of PMDA GMP in Preventing Pharmaceutical Contamination

Posted on By digi

The Role of PMDA GMP in Preventing Pharmaceutical Contamination The Role of PMDA GMP in Preventing Pharmaceutical Contamination Introduction to Pharmaceutical Contamination and PMDA GMP Pharmaceutical contamination is a serious risk that can undermine the safety, efficacy, and quality of drug products, potentially endangering patient health. In Japan, the Pharmaceutical and Medical Devices Agency (PMDA)…

Read More “The Role of PMDA GMP in Preventing Pharmaceutical Contamination” »

PMDA GMP Guidelines

How ANVISA GMP Helps with Drug Stability and Expiry Dates

Posted on By digi

How ANVISA GMP Helps with Drug Stability and Expiry Dates How ANVISA GMP Helps with Drug Stability and Expiry Dates Introduction to ANVISA GMP and Drug Stability The National Health Surveillance Agency (ANVISA) is Brazil’s regulatory body responsible for overseeing the safety, quality, and efficacy of pharmaceutical products. One of the key frameworks enforced by…

Read More “How ANVISA GMP Helps with Drug Stability and Expiry Dates” »

GMP in Latin America (ANVISA, COFEPRIS)

How Schedule M (Revised) GMP Standards Affect the Pharmaceutical Supply Chain in India

Posted on By digi

How Schedule M (Revised) GMP Standards Affect the Pharmaceutical Supply Chain in India The Impact of Schedule M (Revised) GMP Standards on India’s Pharmaceutical Supply Chain Introduction to Schedule M (Revised) and the Pharmaceutical Supply Chain The pharmaceutical supply chain is a complex network encompassing raw material procurement, manufacturing, storage, distribution, and delivery to end-users….

Read More “How Schedule M (Revised) GMP Standards Affect the Pharmaceutical Supply Chain in India” »

SCHEDULE - M - Revised